Laboratorios Richmond SACIF is an Argentine pharmaceutical company that was founded in 1950. It is a leading manufacturer and marketer of generics in Argentina and one of the most important manufacturers in the Latin American market. Laboratorios Richmond SACIF operates three production sites in Argentina and employs over 350 employees.
Generics are medicines that contain the same active ingredient as brand-name drugs, but are sold at a lower price. Laboratorios Richmond SACIF produces a wide range of generics that are used in various therapeutic areas such as cardiology, gastroenterology, pain treatment, oncology, and others.
The company operates in four main areas: generics, biosimilars, medical devices, and veterinary drugs.
In the generics sector, Laboratorios Richmond SACIF offers a variety of products including pills, capsules, injections, eye drops, and ointments. The company produces generics for well-known brand-name drugs such as Viagra, Lipitor, and Zovirax, to name a few.
In the biosimilars sector, Laboratorios Richmond SACIF produces drugs that contain biological molecules and are used to treat diseases such as cancer, rheumatoid arthritis, and multiple sclerosis. Biosimilars are copies of biopharmaceuticals that are manufactured in cells. Laboratorios Richmond SACIF has built an extensive portfolio of biosimilars, including Enbrel, MabThera, and Humira.
In the medical devices sector, Laboratorios Richmond SACIF offers a wide range of products used in medicine, including surgical disposable products, orthopedic implants, and cardiology devices.
In the veterinary drugs sector, the company produces drugs for livestock and pets. Laboratorios Richmond SACIF offers a wide range of veterinary drugs, including antibiotics, vaccines, and anthelmintics.
Laboratorios Richmond SACIF has expanded its presence in Latin America and worldwide, exporting its products to over 50 countries. The company has also established partnerships with international pharmaceutical companies such as Pfizer and Takeda to increase its reach and capacity.
The business model of Laboratorios Richmond SACIF is based on providing high-quality and affordable medicines that cover a wide range of diseases and needs. The company has a clear strategy to expand its position in the Latin American market and diversify its product lines to respond to changing market demands.
Overall, Laboratorios Richmond SACIF is an innovative and strong pharmaceutical company specialized in high-quality generics, biosimilars, medical devices, and veterinary drugs. With its various business sectors, the company is well-positioned to continue growing and increase its market share in the future.
